Sihuan Pharmaceutical submits the Investigation New Drug Application for Self-Developed Category 1.1 Innovative Patented
Recently, Shandong Xuanzhu Pharma Co., Ltd.(“Shandong XuanZhu”), the Group’s innovative drug research anddevelopment division submitted an Investigational New Drug (“IND”)filingofFadanafil(“Fada...
昨日に引き続き四環医薬のホームページでMedia center→News Releaseｓの
１１／２３の日付にupdateされているのは新薬の件か。
